Abstract
We report on a radiopharmaceutical imaging platform designed to capture the kinetics of cellular responses to drugs. Methods: A portable in vitro molecular imaging system comprising a microchip and a bparticle imaging camera permitted routine cell-based radioassays of small numbers of either suspended or adherent cells. We investigated the kinetics of responses of model lymphoma and glioblastoma cancer cell lines to 18F-FDG uptake after drug exposure. Those responses were correlated with kinetic changes in the cell cycle or with changes in receptor tyrosine kinase signaling. Results: The platform enabled direct radioassays of multiple cell types and yielded results comparable to those from conventional approaches; however, the platform used smaller sample sizes, permitted a higher level of quantitation, and did not require cell lysis. Conclusion: The kinetic analysis enabled by the platform provided a rapid (≈1 h) drug screening assay. COPYRIGHT
| Original language | English |
|---|---|
| Pages (from-to) | 1820-1824 |
| Number of pages | 5 |
| Journal | Journal of Nuclear Medicine |
| Volume | 54 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 1 2013 |
Keywords
- Microfluidics
- Molecular imaging
- Radioassay
- Radiopharmaceuticals
Fingerprint
Dive into the research topics of 'Fast metabolic response to drug intervention through analysis on a miniaturized, highly integrated molecular imaging system'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver